Pretreatment prognostic factor for patients with human papillomavirus related oropharyngeal cancer
- PMID: 35116767
- PMCID: PMC8798160
- DOI: 10.21037/tcr.2019.04.02
Pretreatment prognostic factor for patients with human papillomavirus related oropharyngeal cancer
Conflict of interest statement
Conflicts of Interest: Both authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/tcr.2019.04.02). The authors have no conflicts of interest to declare.
Comment on
-
Pretreatment metabolic tumor volume as a prognostic factor in HPV-associated oropharyngeal cancer in the context of AJCC 8th edition staging.Head Neck. 2018 Oct;40(10):2280-2287. doi: 10.1002/hed.25337. Epub 2018 Jul 26. Head Neck. 2018. PMID: 30051553
References
-
- O'Sullivan B, Huang SH, Su J, et al. Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study. Lancet Oncol 2016;17:440-51. 10.1016/S1470-2045(15)00560-4 - DOI - PubMed
-
- Lydiatt WM, Patel SG, O'Sullivan B, et al. Head and Neck cancers-major changes in the American Joint Committee on cancer eighth edition cancer staging manual. CA Cancer J Clin 2017;67:122-37. - PubMed
Publication types
LinkOut - more resources
Full Text Sources